FFEM was created on 2024-11-19 by Fidelity. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 66.53m in AUM and 118 holdings. FFEM seeks to achieve long-term capital growth through an actively managed portfolio of emerging markets stocks selected based on fundamental factors. The fund includes issuers of any market capitalization.
What is the current price of Fidelity Fundamental Emerging Markets ETF (FFEM)?
The current price of Fidelity Fundamental Emerging Markets ETF (FFEM) is 37.02. Market data may be delayed; please refer to the timestamp displayed on the page.
What is the 52-week high of Fidelity Fundamental Emerging Markets ETF?
The 52-week high of Fidelity Fundamental Emerging Markets ETF is 45.41. Please refer to the page timestamp for the latest data.
What is the 52-week low of Fidelity Fundamental Emerging Markets ETF?
The 52-week low of Fidelity Fundamental Emerging Markets ETF is 30.98. Please refer to the page timestamp for the latest data.
What is the NAV of Fidelity Fundamental Emerging Markets ETF?
The NAV of Fidelity Fundamental Emerging Markets ETF is 38.60 today. NAV represents the fund’s total assets minus its liabilities and helps indicate its underlying per-share value.
How is Fidelity Fundamental Emerging Markets ETF (FFEM) performing?
The trading turnover of Fidelity Fundamental Emerging Markets ETF (FFEM) is 16.59K. Its price changed by -10.36% over the past month, while its one-year return is 12.77%. View the Fidelity Fundamental Emerging Markets ETF price chart for more details.
Is Fidelity Fundamental Emerging Markets ETF (FFEM) a safe investment?
No investment is completely risk-free. The risk level of Fidelity Fundamental Emerging Markets ETF (FFEM) depends on its underlying assets, strategy, liquidity, fees, and market conditions. Diversification may reduce potential losses but cannot eliminate them, and past performance does not guarantee future results. Before investing, consider whether the fund aligns with your goals and risk tolerance. This is not investment advice.